News Johnson & Johnson Buenos Aires S.E.

Equities

JNJD

ARDEUT110236

End-of-day quote Buenos Aires S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
9.84 ^USD	-1.60%		-4.93%	-3.53%

28/05	Sector Update: Health Care Stocks Fall Late Afternoon	MT
28/05	Sector Update: Health Care Stocks Retreat Tuesday Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Fall Late Afternoon	29/05	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	28/05	MT
Sector Update: Health Care	28/05	MT
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	28/05	MT
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	28/05	MT
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	28/05	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28/05	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	28/05	MT
Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion	28/05	MT
J&J: acquisition of Swiss eczema biotech company	28/05	CF
J&J to Acquire Skin Disease Treatment Rights from Numab in $1.25 Billion Deal	28/05	DJ
J&J acquires rights to skin disorder drug for $1.25 bln	28/05	RE
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis	28/05	AQ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis	28/05	BU
Johnson & Johnson: Meet a nurse who leads clinical trials to find innovative cancer therapies	24/05	AQ
J&J: to present advances at ASCO and EHA	24/05	CF
Johnson & Johnson : advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA	24/05	PU
Some of the biggest splits in Corporate America	23/05	RE
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	23/05	RE
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	22/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 11:00 pm IST